Calaspargase pegol
Calaspargase Pegol
Calaspargase pegol (pronunciation: kal-as-PAR-gase PEG-ol) is a medicinal drug used in the treatment of acute lymphoblastic leukemia (ALL), a type of cancer that affects the white blood cells.
Etymology
The name "Calaspargase pegol" is derived from the drug's active ingredient, L-asparaginase, which is a type of enzyme that helps to break down asparagine, an amino acid that is essential for the growth of ALL cells. The "pegol" part of the name refers to the process of pegylation, which is used to extend the drug's half-life in the body.
Usage
Calaspargase pegol is used as part of a multi-drug chemotherapy regimen for the treatment of ALL. It is typically administered by intravenous infusion under the supervision of a healthcare professional.
Side Effects
Common side effects of calaspargase pegol include nausea, vomiting, abdominal pain, and fatigue. Serious side effects can include pancreatitis, blood clotting disorders, and allergic reactions.
Related Terms
External links
- Medical encyclopedia article on Calaspargase pegol
- Wikipedia's article - Calaspargase pegol
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski